BiotechTube
Home/Pangolin Therapeutics/Andrew Miranker, PhD
AM

Andrew Miranker, PhD

Co-Founder, Scientific Advisory Board Chair

Pangolin Therapeutics

Therapeutic Areas

OncologyImmunologyMetabolic DiseaseNeurodegeneration

Pangolin Therapeutics Pipeline

DrugIndicationPhase
Undisclosed (Targeting IAPP)Type 2 DiabetesPre-clinical
Undisclosed (Targeting alpha-synuclein)Neurodegeneration (e.g., Parkinson's Disease)Pre-clinical

Leadership Team at Pangolin Therapeutics

EA
Enrique Alvarez Sotomayor
Co-Founder and CEO
View full Pangolin Therapeutics profile